rethinkTHC Search
Menu
Evidence in context

Cannabis and Pregnancy

The research base for cannabis and pregnancy includes 416 peer-reviewed studies spanning 1986–2026. Of these, 49 provide strong evidence, including 9 meta-analyses and 0 randomized controlled trials.

Published summary: 2026-03-07

Where the evidence converges

Meta-analysis of 57 studies found prenatal cannabis exposure increased risks of preterm birth (68%), low birth weight (160%), and NICU admission (151%), with limited cognitive effects beyond attention problems

Strong evidence · 5 studies

Many included studies could not fully control for concurrent tobacco use, socioeconomic factors, or other substance exposure. Self-reported cannabis use likely underestimates exposure. The cognitive l

Meta-analysis of 36 studies and 18 million births found prenatal cannabis exposure associated with 2-3x higher risks of cardiovascular, GI, CNS, and genitourinary birth defects

Strong evidence · 5 studies

Observational studies cannot prove causation. Cannabis use is typically self-reported and likely underestimated. Concurrent substance use (especially tobacco) is difficult to fully disentangle. Differ

Meta-analysis of 14 studies found prenatal cannabis exposure associated with higher ADHD symptom scores and a 30% increased risk of autism, involving over 200,000 participants

Strong evidence · 5 studies

Moderate heterogeneity for ADHD outcome (I2=66.85%). Only 4 studies on ASD limits that analysis. Underlying studies vary in how cannabis exposure was measured. Confounders including concurrent substan

Where questions remain

A major 1986 pharmacological review found cannabis's greatest health concern was its impact on youth development, while finding no proven brain damage and limited physical dependence in adults

Moderate evidence · 65 studies

Reflects evidence available through the mid-1980s. Cannabis potency, usage patterns, and the volume of research have all changed dramatically. The review's reassurance about lung effects preceded mode

In 131 children followed from birth, prenatal cigarette exposure was linked to lower reading and language scores in a dose-dependent pattern, while prenatal marijuana exposure showed no significant effect

Moderate evidence · 65 studies

Predominantly middle-class sample may not generalize to higher-risk populations. The absence of a significant marijuana association does not prove safety, as the study may have been underpowered to de

Prenatal cigarette exposure reduced birth weight but children caught up quickly

Moderate evidence · 65 studies

Head circumference is an imprecise proxy for brain development. The effect reached significance only among heavy users in the early adolescent subgroup. Self-reported prenatal substance use may be ina

fMRI study showing young adults prenatally exposed to marijuana had increased brain activation during impulse control tasks and more errors, with effects persisting after controlling for current drug use

Moderate evidence · 65 studies

The OPPS cohort is relatively small and non-randomly selected. Self-reported prenatal drug use may be inaccurate. The cross-sectional fMRI assessment cannot prove the brain differences were caused by

Research gaps

  • Only 0 randomized controlled trials exist out of 416 studies — most evidence is observational or from reviews.
  • Long-term prospective studies tracking outcomes over 5+ years are largely absent from the literature.
  • Research on diverse populations (different ages, ethnicities, and medical backgrounds) remains limited.

Key studies

Meta-Analysis Links Prenatal Cannabis to Smaller Babies

This meta-analysis pools evidence from multiple studies to provide a clearer picture of prenatal cannabis risks. The significant findings for birth size outcomes add confidence to what individual studies have suggested.

Cannabis Use in Pregnancy Linked to Preterm Birth, Low Birth Weight, and Small Babies Even After Accounting for Tobacco

This is one of the largest and most rigorous analyses of cannabis and pregnancy outcomes. The upgrade from low to moderate certainty evidence, combined with the enormous sample size, substantially strengthens the case that prenatal cannabis use carries real risks to newborns.

Prenatal Cannabis Linked to Preterm Birth, Low Birth Weight, and NICU Stays

This is the most comprehensive meta-analysis to date on prenatal cannabis effects. The birth outcome findings are robust, while the more nuanced cognitive finding (limited to attention/externalizing) pushes back against overly broad claims of developmental harm.

Prenatal Cannabis Linked to Multiple Types of Birth Defects in Large Meta-Analysis

This is the most comprehensive meta-analysis to date linking prenatal cannabis to specific types of structural birth defects. The consistent 2-3x risk increases across multiple organ systems suggests a broad teratogenic effect rather than a system-specific one.

Prenatal Cannabis Exposure Linked to Higher ADHD and Autism Risk in Children

ADHD and ASD are among the most common neurodevelopmental disorders, and identifying modifiable risk factors is a public health priority. This meta-analysis provides pooled evidence that prenatal cannabis exposure may be one such factor.

Meta-analysis found inconsistent evidence linking prenatal cannabis to birth defects, with two specific exceptions

This is the most comprehensive meta-analysis to date on cannabis and birth defects. The finding that most associations disappear after adjustment suggests confounding (tobacco, alcohol, socioeconomic factors) drives much of the apparent risk.

How the research developed

Pre-2000

4 studies published. Predominantly observational and review studies.

2000–2009

9 studies published. Predominantly observational and review studies.

2010–2014

10 studies published. Includes 1 strong-evidence studies.

2015–2019

47 studies published. Includes 3 strong-evidence studies.

2020–present

346 studies published. Includes 9 meta-analyses, 45 strong-evidence studies.

How this summary was assembled

This consensus synthesizes 416 peer-reviewed studies: 9 meta-analyses (2%), 99 observational studies (24%), 74 reviews (18%), 12 case studies (3%), 222 other study types (53%). Studies span from the earliest available research through 2025. Evidence strength ratings reflect study design, sample size, and replication across multiple research groups.

These counts describe the source summary at publication. They may differ from the current library.